Attend the speech of "Dr. Pradeep Kumar Kar" about Integrating Pathology and Genomics as a New Modality to Understand Immunotherapy Response in Cancer at the 14EPUCG2024
Biography: Dr Pradeep Kumar Kar, has a vast experience in the field of oncology, molecular pathology digital pathology and related areas. He has worked for esteemed organisations like JIMPER, Kidwai Memorial Institute of Oncology, Fortis Cancer Institute and Farcast Biosciences.
In his most recent role as a molecular
pathologist at the Biocon Brystol Myers Sqibb Research and Development Center
(BBRC), he has focused on Digital Pathology, and Various complex monoplex and
Multiplex assay and algorithms development along with understanding the role of
Tumor Microenvironment
in IO (Immuno-Oncology) drug response and registance in various cancer types.
Dr Pradeep has completed MD in Pathology from
VSS Medical college and Fellowship in Oncopathology at Kidwai Memorial Cancer
Institute, Bangalore.
He has published several research papers and
also Taught pathology at JIMPER in pondicherry and Kidwai
Memorial Cancer Institute.
-----------------
Integrating Pathology and Genomics
as a New Modality to Understand Immunotherapy Response in
Cancer
-----------------
Integrating pathology and genomics represents a promising approach to
better understand and predict immunotherapy responses in cancer patients. This
integration leverages the strengths of both disciplines to provide a
comprehensive view of the tumor microenvironment, genetic alterations, and
immune interactions. Here are key aspects and strategies for integrating
pathology and genomics to enhance our understanding of immunotherapy responses:
Key Aspects
- Tumor Microenvironment
Analysis:
- Immunohistochemistry
(IHC): Traditional pathology techniques, such as IHC, are
used to assess the presence and distribution of immune cells (e.g., T
cells, macrophages) within the tumor microenvironment.
- Spatial Transcriptomics: Combining
IHC with spatial transcriptomics enables the mapping of gene expression
profiles within specific regions of the tumor, revealing the spatial
organization of immune cells and their interactions with tumor cells.
- Genomic Profiling:
- Next-Generation Sequencing
(NGS): Genomic profiling using NGS identifies mutations,
copy number variations, and other genetic alterations that may influence
immunotherapy responses.
- Tumor Mutational Burden
(TMB): High TMB has been associated with better responses
to immune checkpoint inhibitors, making it a crucial genomic marker for
immunotherapy prediction.
- Molecular Pathology:
- Gene Expression
Signatures: Analysis of gene expression signatures can help
identify tumors with specific immune-related characteristics, such as the
presence of interferon-gamma signaling or the expression of immune
checkpoint molecules (e.g., PD-L1, CTLA-4).
- Neoantigen Prediction: Sequencing data can be used to
predict neoantigens—novel peptides presented by tumor cells that can be
recognized by the immune system, potentially driving an anti-tumor
response.
- Single-Cell
Analysis:
- Single-Cell
RNA Sequencing (scRNA-seq): This technology allows for the
characterization of individual cells within the tumor microenvironment,
providing insights into the heterogeneity of immune cell populations and
their functional states.
- Cytometry by Time
of Flight (CyTOF): A single-cell analysis
technique that combines flow cytometry and mass spectrometry to
simultaneously measure multiple protein markers on individual cells,
offering a detailed view of immune cell phenotypes.
- Bioinformatics and
Data Integration:
- Multi-Omics
Integration: Combining data from genomics, transcriptomics,
proteomics, and pathology to create a comprehensive profile of the tumor
and its microenvironment.
- Machine Learning: Utilizing
machine learning algorithms to analyze complex datasets and identify
patterns or biomarkers predictive of immunotherapy response.
Strategies for Implementation
- Collaborative Research:
- Foster
collaborations between pathologists, genomic scientists,
bioinformaticians, and oncologists to develop integrated approaches for
studying immunotherapy responses.
- Establish
multi-disciplinary research teams and consortia to share data and
resources.
- Clinical Trials:
- Incorporate
integrated pathology and genomics analyses into clinical trials to
prospectively evaluate their predictive value for immunotherapy outcomes.
- Use adaptive
trial designs that allow for the incorporation of new biomarkers and
technologies as they become available.
- Standardization and
Validation:
- Develop
standardized protocols for tissue handling, processing, and analysis to
ensure reproducibility and reliability of results.
- Validate
predictive biomarkers and models in independent cohorts and clinical
settings.
- Translational Research:
- Focus on
translating findings from integrated pathology and genomics research into
clinical practice by developing companion diagnostics and personalized
treatment strategies.
- Implement precision oncology approaches that tailor immunotherapy
treatments based on the integrated profiles of individual patients'
tumors.
----------------
Conference Name: 14th
Emirates Pathology, Digital Pathology & Cancer Conference
Short
Name: 14EPUCG2024
Dates:
December 17-19, 2024
Venue:
Holiday Inn Dubai, UAE & Online
Email: pathology@universeconferences.net
Email:
pathology@universeconferences.com
| Call Us: +1 (207) 707-7298
Visit:
https://pathology.universeconferences.com/
Submit
here: https://pathology.universeconferences.com/submit-abstract/
Register
here: https://pathology.universeconferences.com/registration/
Online Registration here: https://pathology.universeconferences.com/virtual-registration/
WhatsApp
us at: https://wa.me/442033222718?text=
#PathologyConference
#BioTechEvents #MedicalConferences #ScienceEvents #ResearchSymposium #cytology
#pathology #histology #microscope #laboratory #science ##LivingWithCancer
#CancerCare #BrainTumorSymptoms #FightCancer #PathologyTechnology #AIMedTech
#SmartPathology #AIinMedicine #DigitalHealth #AIAlgorithms
#MachineLearningInPathology #Telepathology #RemotePathology #ScienceCommunication #MedEd
#ResearchCommunity #ScientificResearch #LabLife #Biotech #HealthTech cytopathology
#microbiology #anatomicpathology #medical #labtech #cytopath #cyto #pathologist
#clinicalpathology #cell #cancer #biochemistry #specialstains #anatomy
#hematology #laboratorylife #nucleus #MedicalDiagnosis #Histopathology
#DigitalPathology #MolecularPathology #ClinicalResearch #Pathologist
#WomenInMedicine #CME #CPD #BrainTumorSurvivor #BrainTumorAwareness
#TumorDiagnosis #CancerTreatment #DigitalPathology #PathologyResident
#MedicalEducation #ContinuingEducation #PathologyConference #MedicalConference
#HealthcareConference #Networking #DigitalPathology #AIinHealthcare
#AIDiagnostics #PathologyAI #DigitalDiagnosis #AIPathology #MedicalAI #HealthcareInnovation
#BrainTumors #BrainCancer #Glioma #Meningioma #Medulloblastoma
#PituitaryAdenoma #citologia #medicine #biology #cells #microscopy
#histopathology #anatomiapatologica #Immunohistochemistry #IHC #Pathology
#Histology #Immunology #MolecularBiology #CancerDiagnostics #TumorMarkers
#CancerResearch #BiomarkerDiscovery #DiseaseMechanisms #MedicalResearch
#ClinicalPathology #AntibodyStaining #AntigenRetrieval #FluorescenceMicroscopy
#ChromogenicDetection #TissueAnalysis #LabTechniques #Microscopy
Comments
Post a Comment